Glycobiology is a branch of biology that deals with study of structure, function, and biosynthesis of saccharides (carbohydrates and carbohydrates containing molecules), which is the fundamental to all biological systems that may exist in pure form or are associated with other biological molecules to form glycoconjugates. Saccharides are ubiquitously present on cell surfaces, mediating cell interactions, and are relevant to almost all areas of biological research. Glycoconjugates and polysaccharides play a vital structural role in connective tissues. Advancements in the field of glycobiology has thrown light on various complicated biological processes linked to molecular and cellular communication, disease diagnosis and treatment, and developmental biology. Glycomics is the pursuit to decipher the information communicated by carbohydrate molecules – the carbohydrate code or glycocode.
This Market Study offers forecast of the global glycobiology market between 2016 and 2024. In terms of value, the market is expected to register a CAGR of 12.8% during the forecast period. The study demonstrates market dynamics that are expected to influence the current environment and future status of the global glycobiology market over the forecast period. It includes key trends, drivers, restraints, and opportunities influencing growth of the global glycobiology market over forecast period 2016–2024. Impact analysis of key growth drivers and restraints are included in this report to better equip clients with crystal clear decision-making insights.
The global glycobiology market is segmented on the basis of: Product Type Application End User Region
Get Sample Copy of this report at https://www.xploremr.com/connectus/sample/1038
On the basis of product type, the market is segmented as follows: Instruments Enzymes Consumables Reagent Kits
Enzymes product type segment is estimated to account for highest revenue share of 53.0% in 2016, and is expected to register a higher CAGR as compared to other product type segments during forecast period 2016–2024.
On the basis of application, the market is segmented as follows: Drug Discovery and Development Diagnostic Application Oncology Immunology Others Industrial Application Therapeutic Application Oncology Immunology Others Others
“Drug discovery and development application segment is expected to witness highest growth at a CAGR of 13.4% during the forecast period”.
Get Discount on this report at https://www.xploremr.com/connectus/check-discount/1038
On the basis of end user, the market is segmented as follows: Biopharmaceutical Companies Research Laboratories Hospitals Diagnostic Centers Contract Research Organizations Biotechnology Industry Academic Institutions Others
On the basis of region/country, the market is segmented as follows: North America U.S. Canada Latin America Brazil Mexico Rest of Latin America Europe France Germany Italy Spain U.K. Russia Rest of Europe Asia Pacific China India Japan Australia & New Zealand ASEAN Rest of APAC Middle East & Africa GCC countries South Africa Rest of MEA
North America glycobiology market is estimated to account for 44.2% revenue share in 2016, and is expected to dominate the global glycobiology market over the forecast period. APAC glycobiology market is expected to register a higher CAGR as compared to other regions.
Some key market participants included in XploreMR’s global glycobiology market include Merck KGaA, Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific, Inc., Shimadzu Corporation, Plexera Bioscience LLC, New England Biolabs Inc., Agilent Technologies, Inc., and ProZyme, Inc.
Key features of this report Drivers and restraints Latest product innovations and key developments in the market Analysis of business strategies of top players Glycobiology market estimates and forecast
Buy Full Report at https://www.xploremr.com/cart/1038/SL